Brivanib (B) in advanced ovarian cancer (OC): Subset results of a phase 2 randomized discontinuation trial (RDT) Meeting Abstract
| Authors: | Kaye, S. B.; Siu, L. L.; Jassem, J.; Medioni, J.; Soetekouw, Pmmb; Slater, S.; Rudin, C. M.; Schwartz, G. K.; De Jonge, M.; O'Dwyer, P.; Baudelet, C.; Chen, A.; Ratain, M. J. |
| Abstract Title: | Brivanib (B) in advanced ovarian cancer (OC): Subset results of a phase 2 randomized discontinuation trial (RDT) |
| Meeting Title: | 37th Congress of the European Society for Medical Oncology (ESMO) |
| Journal Title: | Annals of Oncology |
| Volume: | 23 |
| Issue: | Suppl. 9 |
| Meeting Dates: | 2012 Sep 28-Oct 2 |
| Meeting Location: | Vienna, Austria |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2012-09-01 |
| Start Page: | ix319 |
| Language: | English |
| ACCESSION: | WOS:000309409001447 |
| PROVIDER: | wos |
| PUBMED: | 23012731 |
| DOI: | 10.1093/annonc/mds401 |
| Notes: | Meeting Abstract: 966O -- "Source: Wos" |
